Literature DB >> 35841519

Unravelling a novel, promising and convenient tool for differential diagnosis of delayed puberty: GnRHa-stimulated inhibin B (GnRH-iB).

S Chaudhary1, R Walia2, A Bhansali1, D Dayal3, N Sachdeva1, T Singh4, S K Bhadada1.   

Abstract

BACKGROUND: Etiological diagnosis of delayed puberty is difficult. Despite availability of various basal and stimulation tests differentiation between constitutional delay in puberty and hypogonadotropic hypogonadism is still challenging.
OBJECTIVE: To elucidate the role of GnRH agonist-stimulated inhibin B (GnRH-iB) for the differential diagnosis of delayed puberty. STUDY
DESIGN: Participants were recruited into "exploratory cohort" (n = 39) and "validation cohort" (n = 16). "Exploratory cohort" included children with spontaneous puberty and patients with hypogonadotropic hypogonadism. "Validation cohort" constituted children who presented with delayed puberty. INTERVENTION AND OUTCOME: GnRHa (Triptorelin) stimulation test along with measurement of inhibin B level at 24 h after GnRHa injection was performed in all the study participants. Cut-offs for GnRH-iB were derived from the "exploratory cohort". These cut-offs were applied to the "validation cohort". Basal LH, basal inhibin B(INH-B), GnRHa-stimulated LH at 4 h (GnRH-LH) and GnRH-iB were evaluated for the prediction of onset of puberty on prospective follow-up.
RESULTS: GnRH-iB at a cut-off value of 113.5 pg/ml in boys and 72.6 pg/ml in girls had 100% sensitivity and specificity for the documentation of puberty. In the "validation cohort" basal LH, basal INH-B, GnRH-LH, and GnRH-iB had a diagnostic accuracy of 68.75%, 81.25%, 68.75% and 93.75% respectively, for the prediction of onset of puberty. Basal LH, basal INH-B and GnRH-LH used alone or in combination were inferior to GnRH-iB used alone.
CONCLUSION: GnRHa-stimulated inhibin B (GnRH-iB) is a convenient and easily employable test for the differentiation of constitutional delay in puberty from hypogonadotropic hypogonadism. CTRI REGISTRATION NO: CTRI/2019/10/021570.
© 2022. The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE).

Entities:  

Keywords:  Constitutional delay in growth and puberty; Delayed puberty; GnRH agonist-stimulated inhibin B; Hypogonadotropic hypogonadism; Inhibin B

Year:  2022        PMID: 35841519     DOI: 10.1007/s40618-022-01858-8

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   5.467


  3 in total

1.  Congenital hypogonadotropic hypogonadism, functional hypogonadotropism or constitutional delay of growth and puberty? An analysis of a large patient series from a single tertiary center.

Authors:  Tero Varimo; Päivi J Miettinen; Johanna Känsäkoski; Taneli Raivio; Matti Hero
Journal:  Hum Reprod       Date:  2016-12-06       Impact factor: 6.918

2.  FSH stimulated inhibin B (FSH-iB): A novel marker for the accurate prediction of pubertal outcome in delayed puberty.

Authors:  Shakun Chaudhary; Rama Walia; Anil Bhansali; Devi Dayal; Naresh Sachdeva; Tulika Singh; Sanjay Kumar Bhadada
Journal:  J Clin Endocrinol Metab       Date:  2021-05-19       Impact factor: 5.958

3.  Plasma inhibin B and antimüllerian hormone concentrations in boys: discriminating between congenital hypogonadotropic hypogonadism and constitutional pubertal delay.

Authors:  Luis Adan; Pauline Lechevalier; Ana-Claudia Couto-Silva; Mathieu Boissan; Christine Trivin; Sylvie Brailly-Tabard; Raja Brauner
Journal:  Med Sci Monit       Date:  2010-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.